235 related articles for article (PubMed ID: 31708414)
1. A centralized communication network: Recent insights into the role of the cancer associated fibroblast in the development of drug resistance in tumors.
Leask A
Semin Cell Dev Biol; 2020 May; 101():111-114. PubMed ID: 31708414
[TBL] [Abstract][Full Text] [Related]
2. Activation of cancer-associated fibroblasts is required for tumor neovascularization in a murine model of melanoma.
Hutchenreuther J; Vincent K; Norley C; Racanelli M; Gruber SB; Johnson TM; Fullen DR; Raskin L; Perbal B; Holdsworth DW; Postovit LM; Leask A
Matrix Biol; 2018 Dec; 74():52-61. PubMed ID: 29885461
[TBL] [Abstract][Full Text] [Related]
3. Broadening Drug Design and Targets to Tumor Microenvironment? Cancer-Associated Fibroblast Marker Expression in Cancers and Relevance for Survival Outcomes.
Dzobo K; Dandara C
OMICS; 2020 Jun; 24(6):340-351. PubMed ID: 32496971
[TBL] [Abstract][Full Text] [Related]
4. Insights into Fibroblast Plasticity: Cellular Communication Network 2 Is Required for Activation of Cancer-Associated Fibroblasts in a Murine Model of Melanoma.
Tsang M; Quesnel K; Vincent K; Hutchenreuther J; Postovit LM; Leask A
Am J Pathol; 2020 Jan; 190(1):206-221. PubMed ID: 31610176
[TBL] [Abstract][Full Text] [Related]
5. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
Dzobo K; Dandara C
OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
[TBL] [Abstract][Full Text] [Related]
6. Cancer associated-fibroblast-derived exosomes in cancer progression.
Li C; Teixeira AF; Zhu HJ; Ten Dijke P
Mol Cancer; 2021 Dec; 20(1):154. PubMed ID: 34852849
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of cancer-associated fibroblasts: Opportunities for precision medicine.
Kanzaki R; Pietras K
Cancer Sci; 2020 Aug; 111(8):2708-2717. PubMed ID: 32573845
[TBL] [Abstract][Full Text] [Related]
8. miRNAs Delivery for Cancer-associated Fibroblasts' Activation and Drug Resistance in Cancer Microenvironment.
Anajafi S; Paryan M; Khoshnazar A; Soleimani M; Mohammadi-Yeganeh S
Endocr Metab Immune Disord Drug Targets; 2024; 24(3):333-347. PubMed ID: 37612874
[TBL] [Abstract][Full Text] [Related]
9. Cancer-associated Fibroblast-specific Expression of the Matricellular Protein CCN1 Coordinates Neovascularization and Stroma Deposition in Melanoma Metastasis.
Hutchenreuther J; Nguyen J; Quesnel K; Vincent KM; Petitjean L; Bourgeois S; Boyd M; Bou-Gharios G; Postovit LM; Leask A
Cancer Res Commun; 2024 Feb; 4(2):556-570. PubMed ID: 38363129
[TBL] [Abstract][Full Text] [Related]
10. Versatility of Cancer Associated Fibroblasts: Commendable Targets for Anti-tumor Therapy.
Khan GJ; Sun L; Khan S; Yuan S; Nongyue H
Curr Drug Targets; 2018; 19(13):1573-1588. PubMed ID: 29468965
[TBL] [Abstract][Full Text] [Related]
11. Cancer-associated fibroblasts mediated chemoresistance by a FOXO1/TGFβ1 signaling loop in esophageal squamous cell carcinoma.
Zhang H; Xie C; Yue J; Jiang Z; Zhou R; Xie R; Wang Y; Wu S
Mol Carcinog; 2017 Mar; 56(3):1150-1163. PubMed ID: 27769097
[TBL] [Abstract][Full Text] [Related]
12. Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance.
Fiori ME; Di Franco S; Villanova L; Bianca P; Stassi G; De Maria R
Mol Cancer; 2019 Mar; 18(1):70. PubMed ID: 30927908
[TBL] [Abstract][Full Text] [Related]
13. Cancer-associated fibroblasts in desmoplastic tumors: emerging role of integrins.
Zeltz C; Primac I; Erusappan P; Alam J; Noel A; Gullberg D
Semin Cancer Biol; 2020 May; 62():166-181. PubMed ID: 31415910
[TBL] [Abstract][Full Text] [Related]
14. Repurposed drug screen identifies cardiac glycosides as inhibitors of TGF-β-induced cancer-associated fibroblast differentiation.
Coleman DT; Gray AL; Stephens CA; Scott ML; Cardelli JA
Oncotarget; 2016 May; 7(22):32200-9. PubMed ID: 27058757
[TBL] [Abstract][Full Text] [Related]
15. Human cancer-associated fibroblasts enhance glutathione levels and antagonize drug-induced prostate cancer cell death.
Cheteh EH; Augsten M; Rundqvist H; Bianchi J; Sarne V; Egevad L; Bykov VJ; Östman A; Wiman KG
Cell Death Dis; 2017 Jun; 8(6):e2848. PubMed ID: 28569790
[TBL] [Abstract][Full Text] [Related]
16. In search of definitions: Cancer-associated fibroblasts and their markers.
Nurmik M; Ullmann P; Rodriguez F; Haan S; Letellier E
Int J Cancer; 2020 Feb; 146(4):895-905. PubMed ID: 30734283
[TBL] [Abstract][Full Text] [Related]
17. Anti-metastatic potential of somatostatin analog SOM230: Indirect pharmacological targeting of pancreatic cancer-associated fibroblasts.
Moatassim-Billah S; Duluc C; Samain R; Jean C; Perraud A; Decaup E; Cassant-Sourdy S; Bakri Y; Selves J; Schmid H; Martineau Y; Mathonnet M; Pyronnet S; Bousquet C
Oncotarget; 2016 Jul; 7(27):41584-41598. PubMed ID: 27177087
[TBL] [Abstract][Full Text] [Related]
18. Targeting nuclear receptors in cancer-associated fibroblasts as concurrent therapy to inhibit development of chemoresistant tumors.
Chan JSK; Sng MK; Teo ZQ; Chong HC; Twang JS; Tan NS
Oncogene; 2018 Jan; 37(2):160-173. PubMed ID: 28892046
[TBL] [Abstract][Full Text] [Related]
19. Diversity and Biology of Cancer-Associated Fibroblasts.
Biffi G; Tuveson DA
Physiol Rev; 2021 Jan; 101(1):147-176. PubMed ID: 32466724
[TBL] [Abstract][Full Text] [Related]
20. Active autophagy in cancer-associated fibroblasts: Recent advances in understanding the novel mechanism of tumor progression and therapeutic response.
Jena BC; Rout L; Dey A; Mandal M
J Cell Physiol; 2021 Nov; 236(11):7887-7902. PubMed ID: 34008184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
